27. May 2019 | Medtech
Wood-based innovation for wound care receives regulatory approval and CE markUPM launches a new advanced wound care product for the European market.
FibDex is the first wound dressing created from wood-based nanofibrillar cellulose to receive regulatory approval and be awarded a CE mark. Nanofibrillar cellulose, which has been shown to be biocompatible with human cells and tissue, forms the core of the dressing. The proprietary nanotechnology, combined with over a decade of research into nanofibrillar cellulose and a highly professional R&D, has resulted in the development of this unique product.
In clinical trials FibDex was shown to provide a favourable environment for healing to occur. Moreover, FibDex is a one-time only application dressing that peels away from the treatment site once healing has occurred. This makes the process less painful for patients and more efficient from the perspective of the hospital.
Prior to receiving the CE mark, FibDex has undergone vigorous preclinical safety and efficacy tests followed by clinical trials that have centered on the treatment of skin graft donor sites. FibDex is manufactured from renewable and responsibly sourced Finnish birch wood.